Physics-based ML framework designs IDPs—biomolecules without fixed structures that underlie key functions and diseases such as Parkinson’s.
In a recent paper titled The Philosophic Turn for AI Agents, Oxford philosopher Philipp Koralus offers something rare in the ...
Pharmaceutical and biotech companies are making huge investments in lab automation technologies, but what’s the ROI?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback